Healthier Choices Management Corp. - Quarter Report: 2020 June (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2020
Or
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _____ to _____
Commission file number: 001-36469
HEALTHIER CHOICES MANAGEMENT CORP.
(Exact name of Registrant as specified in its charter)
Delaware
|
84-1070932
|
|
(State or other jurisdiction of
|
(I.R.S. Employer
|
|
incorporation or organization)
|
Identification No.)
|
|
3800 North 28Th Way
|
||
Hollywood, FL
|
33020
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code: 305-600-5004
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
☒ Yes ☐ No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every
Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
☒ Yes ☐ No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller
reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
|
☐
|
Accelerated filer
|
☐
|
Non-accelerated filer
|
☒
|
Smaller reporting company
|
☒
|
Emerging growth company
|
☐
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
☐ Yes ☒ No
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
Trading Symbol
|
Name of each exchange on which registered
|
||
Common Stock, par value $0.0001 per share
|
HCMC
|
OTC Pink Marketplace
|
As of August 19, 2020, there were 105,110,848,016 shares of the registrant’s common stock, par value $0.0001 per share, outstanding.
TABLE OF CONTENTS
PAGE
|
|
1
|
|
1
|
|
1
|
|
2
|
|
3
|
|
5
|
|
6
|
|
10
|
|
16
|
|
16
|
|
17
|
|
17
|
|
17
|
|
17
|
|
17
|
|
17
|
|
17
|
|
18
|
|
19
|
|
CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
June 30,
2020
|
December 31,
2019
|
||||
ASSETS
|
|||||
CURRENT ASSETS
|
|||||
Cash and cash equivalents
|
$
|
1,147,103
|
$
|
1,525,415
|
|
Accounts receivable, net
|
26,992
|
65,401
|
|||
Inventories
|
1,779,923
|
1,757,012
|
|||
Prepaid expenses and vendor deposits
|
298,520
|
269,833
|
|||
Investment
|
12,857
|
24,000
|
|||
TOTAL CURRENT ASSETS
|
3,265,395
|
3,641,661
|
|||
Restricted cash
|
2,000,000
|
2,000,000
|
|||
Property and equipment, net of accumulated depreciation
|
287,837
|
332,290
|
|||
Intangible assets, net of accumulated amortization
|
1,795,418
|
1,923,447
|
|||
Goodwill
|
956,000
|
956,000
|
|||
Note receivable
|
333,396
|
343,387
|
|||
Right of use asset – operating lease, net
|
4,396,343
|
4,663,019
|
|||
Other assets
|
142,668
|
146,865
|
|||
TOTAL ASSETS
|
$
|
13,177,057
|
$
|
14,006,669
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|||||
CURRENT LIABILITIES
|
|||||
Accounts payable and accrued expenses
|
$
|
929,799
|
$
|
825,860
|
|
Contract liabilities
|
21,386
|
26,823
|
|||
Current portion of line of credit
|
2,000,000
|
2,000,000
|
|||
Current portion of loan payment
|
651,187
|
282,344
|
|||
Operating lease liability, current
|
536,152
|
555,959
|
|||
TOTAL CURRENT LIABILITIES
|
4,138,524
|
3,690,986
|
|||
Loan payable, net of current portion
|
1,237,060
|
869,223
|
|||
Operating lease liability, net of current
|
3,335,437
|
3,544,729
|
|||
TOTAL LIABILITIES
|
8,711,021
|
8,104,938
|
|||
COMMITMENTS AND CONTINGENCIES (SEE NOTE 8)
|
|||||
STOCKHOLDERS’ EQUITY
|
|||||
Series B convertible preferred stock, $1,000 par value per share, 30,000 shares authorized; 20,150 shares
issued and outstanding as of June 30, 2020 and December 31, 2019; aggregate liquidation preference of $20.2 million
|
20,150,116
|
20,150,116
|
|||
Common Stock, $0.0001 par value per share, 750,000,000,000 shares authorized; approximately 87.6 and 67.7
billion shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively
|
8,755,829
|
6,769,849
|
|||
Additional paid-in capital
|
5,706,544
|
7,618,245
|
|||
Accumulated deficit
|
(30,146,453)
|
(28,636,479)
|
|||
TOTAL STOCKHOLDERS’ EQUITY
|
4,466,036
|
5,901,731
|
|||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
|
$
|
13,177,057
|
$
|
14,006,669
|
See notes to unaudited condensed consolidated financial statements
1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
Three Months Ended
|
Six Months Ended
|
||||||||||
June 30,
|
June 30,
|
||||||||||
2020
|
2019
|
2020
|
2019
|
||||||||
SALES
|
|||||||||||
Vapor sales, net
|
$
|
520,877
|
$
|
1,085,259
|
$
|
1,294,334
|
$
|
2,309,300
|
|||
Grocery sales, net
|
2,788,035
|
2,731,754
|
6,050,749
|
5,887,819
|
|||||||
TOTAL SALES, NET
|
3,308,912
|
3,817,013
|
7,345,083
|
8,197,119
|
|||||||
Cost of sales vapor
|
212,457
|
442,931
|
531,537
|
952,347
|
|||||||
Cost of sales grocery
|
1,723,161
|
1,711,791
|
3,732,362
|
3,679,587
|
|||||||
GROSS PROFIT
|
1,373,294
|
1,662,291
|
3,081,184
|
3,565,185
|
|||||||
OPERATING EXPENSES
|
2,168,159
|
2,534,492
|
4,540,540
|
5,524,947
|
|||||||
LOSS FROM OPERATIONS
|
(794,865)
|
(872,201)
|
(1,459,356)
|
(1,959,762)
|
|||||||
OTHER (EXPENSE) INCOME
|
|||||||||||
Gain (loss) on investment
|
(1,286)
|
(19,286)
|
(11,143)
|
(44,999)
|
|||||||
Interest income (expense), net
|
(22,529)
|
(12,827)
|
(39,475)
|
(12,082)
|
|||||||
Total other (expense) income, net
|
(23,815)
|
(32,113)
|
(50,618)
|
(57,081)
|
|||||||
NET LOSS
|
$
|
(818,680)
|
$
|
(904,314)
|
$
|
(1,509,974)
|
$
|
(2,016,843)
|
|||
NET LOSS PER SHARE-BASIC AND DILUTED
|
$
|
0.00
|
$
|
0.00
|
$
|
0.00
|
$
|
0.00
|
|||
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING-BASIC AND DILUTED
|
81,189,670,235
|
66,642,629,630
|
75,564,076,780
|
66,635,948,138
|
See notes to unaudited condensed consolidated financial statements
2
CONDENSED CONSOLIDATED STOCKHOLDERS’ EQUITY STATEMENTS
FOR THE THREE MONTHS ENDED JUNE 30, 2020
(UNAUDITED)
Convertible
Preferred Stock
|
Common Stock
|
Additional
Paid-In
|
Accumulated
|
|||||||||||||||||
Shares
|
Amount
|
Shares
|
Amount
|
Capital
|
Deficit
|
Total
|
||||||||||||||
Balance – April 1, 2020
|
20,150
|
$
|
20,150,116
|
72,497,427,011
|
$
|
7,249,743
|
$
|
7,220,295
|
$
|
(29,327,773)
|
$
|
5,292,381
|
||||||||
Issuance of common stock in connection with cashless exercise of Series A warrants
|
-
|
-
|
15,060,869,587
|
1,506,086
|
(1,506,086)
|
-
|
-
|
|||||||||||||
Stock-based compensation expense
|
-
|
-
|
-
|
-
|
(7,665)
|
-
|
(7,665)
|
|||||||||||||
Net loss
|
-
|
-
|
-
|
-
|
-
|
(818,680)
|
(818,680)
|
|||||||||||||
Balance – June 30, 2020
|
20,150
|
$
|
20,150,116
|
87,558,296,598
|
$
|
8,755,829
|
$
|
5,706,544
|
$
|
(30,146,453)
|
$
|
4,466,036
|
HEALTHIER CHOICES MANAGEMENT CORP.
CONDENSED CONSOLIDATED STOCKHOLDERS’ EQUITY STATEMENTS
FOR THE THREE MONTHS ENDED JUNE 30, 2019
(UNAUDITED)
Convertible
Preferred Stock
|
Common Stock
|
Additional
Paid-In
|
Accumulated
|
|||||||||||||||||
Shares
|
Amount
|
Shares
|
Amount
|
Capital
|
Deficit
|
Total
|
||||||||||||||
Balance – April 1, 2019
|
20,150
|
$
|
20,150,116
|
66,634,387,066
|
$
|
6,663,438
|
$
|
7,460,832
|
$
|
(26,949,632)
|
$
|
7,324,754
|
||||||||
Issuance of common stock in connection with cashless exercise of Series A warrants
|
-
|
-
|
10,870,628
|
1,088
|
(637)
|
-
|
451
|
|||||||||||||
Stock-based compensation expense
|
-
|
-
|
-
|
-
|
83,175
|
-
|
83,175
|
|||||||||||||
Net loss
|
(904,314)
|
(904,314)
|
||||||||||||||||||
Balance – June 30, 2019
|
20,150
|
$
|
20,150,116
|
66,645,257,694
|
$
|
6,664,526
|
$
|
7,543,370
|
$
|
(27,853,946)
|
$
|
6,504,066
|
See notes to unaudited condensed consolidated financial statements
3
CONDENSED CONSOLIDATED STOCKHOLDERS’ EQUITY STATEMENTS
FOR THE SIX MONTHS ENDED JUNE 30, 2020
(UNAUDITED)
Convertible
Preferred Stock
|
Common Stock
|
Additional
Paid-In
|
Accumulated
|
|||||||||||||||||
Shares
|
Amount
|
Shares
|
Amount
|
Capital
|
Deficit
|
Total
|
||||||||||||||
Balance – January 1, 2020
|
20,150
|
$
|
20,150,116
|
67,698,494,244
|
$
|
6,769,849
|
$
|
7,618,245
|
$
|
(28,636,479)
|
$
|
5,901,731
|
||||||||
Issuance of common stock in connection with cashless exercise of Series A warrants
|
-
|
-
|
19,859,802,354
|
1,985,980
|
(1,985,980)
|
-
|
-
|
|||||||||||||
Stock-based compensation expense
|
-
|
-
|
-
|
-
|
74,279
|
-
|
74,279
|
|||||||||||||
Net loss
|
-
|
-
|
-
|
-
|
-
|
(1,509,974)
|
(1,509,974)
|
|||||||||||||
Balance – June 30, 2020
|
20,150
|
$
|
20,150,116
|
87,558,296,598
|
$
|
8,755,829
|
$
|
5,706,544
|
$
|
(30,146,453)
|
$
|
4,466,036
|
HEALTHIER CHOICES MANAGEMENT CORP.
CONDENSED CONSOLIDATED STOCKHOLDERS’ EQUITY STATEMENTS
FOR THE SIX MONTHS ENDED JUNE 30, 2019
(UNAUDITED)
Convertible
Preferred Stock
|
Common Stock
|
Additional
Paid-In
|
Accumulated
|
|||||||||||||||||
Shares
|
Amount
|
Shares
|
Amount
|
Capital
|
Deficit
|
Total
|
||||||||||||||
Balance – January 1, 2019
|
20,150
|
$
|
20,150,116
|
66,623,514,522
|
$
|
6,662,351
|
$
|
7,348,390
|
$
|
(25,734,088)
|
$
|
8,426,769
|
||||||||
Issuance of common stock in connection with cashless exercise of Series A warrants
|
-
|
-
|
21,743,172
|
2,175
|
(1,274)
|
-
|
901
|
|||||||||||||
Cumulative Effect on adoption of ASC 842
|
-
|
-
|
-
|
-
|
-
|
(103,015)
|
(103,015)
|
|||||||||||||
Stock-based compensation expense
|
-
|
-
|
-
|
-
|
196,254
|
-
|
196,254
|
|||||||||||||
Net loss
|
-
|
-
|
-
|
-
|
-
|
(2,016,843)
|
(2,016,843)
|
|||||||||||||
Balance – June 30, 2019
|
20,150
|
$
|
20,150,116
|
66,645,257,694
|
$
|
6,664,526
|
$
|
7,543,370
|
$
|
(27,853,946)
|
$
|
6,504,066
|
See notes to unaudited condensed consolidated financial statements
4
HEALTHIER CHOICES MANAGEMENT CORP.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
Six Months Ended June 30,
|
|||||
2020
|
2019
|
||||
OPERATING ACTIVITIES
|
|||||
Net loss
|
$
|
(1,509,974)
|
$
|
(2,016,843)
|
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
|||||
Depreciation and amortization
|
286,559
|
302,277
|
|||
Loss on disposal of assets
|
-
|
25,427
|
|||
Loss on investment
|
11,143
|
44,999
|
|||
Amortization of right-of-use asset
|
266,676
|
327,287
|
|||
Stock-based compensation expense
|
74,279
|
196,254
|
|||
Changes in operating assets and liabilities:
|
|||||
Accounts receivable
|
38,409
|
11,662
|
|||
Inventories
|
(22,911)
|
(153,951)
|
|||
Prepaid expenses and vendor deposits
|
(28,687)
|
34,893
|
|||
Contract assets
|
-
|
14,400
|
|||
Other assets
|
4,197
|
320
|
|||
Accounts payable
|
119,686
|
9,526
|
|||
Accrued expenses
|
(15,747)
|
(322,140)
|
|||
Contract liabilities
|
(5,437)
|
(275,249)
|
|||
Lease liability
|
(229,098)
|
(288,850)
|
|||
NET CASH USED IN OPERATING ACTIVITIES
|
(1,010,905)
|
(2,089,988)
|
|||
INVESTING ACTIVITIES
|
|||||
Collection of note receivable
|
9,991
|
87,154
|
|||
Purchases of property and equipment
|
(24,663)
|
(4,584)
|
|||
Purchases of patent
|
(89,415)
|
(25,000)
|
|||
NET CASH USED IN INVESTING ACTIVITIES
|
(104,087)
|
57,570
|
|||
FINANCING ACTIVITIES
|
|||||
Proceeds from line of credit
|
-
|
131,540
|
|||
Principal payments on loan payable
|
736,680
|
(117,763)
|
|||
NET CASH USED IN FINANCING ACTIVITIES
|
736,680
|
13,777
|
|||
NET DECREASE IN CASH, CASH EQUIVALENT AND RESTRICTED CASH
|
(378,312)
|
(2,018,641)
|
|||
CASH, CASH EQUIVALENTS AND RESTRICTED CASH— BEGINNING OF PERIOD
|
3,525,415
|
7,061,253
|
|||
CASH, CASH EQUIVALENTS AND RESTRICTED CASH — END OF PERIOD
|
$
|
3,147,103
|
$
|
5,042,612
|
|
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
|
|||||
Cash paid for interest
|
$
|
69,520
|
$
|
69,220
|
See notes to unaudited condensed consolidated financial statements
5
Note 1. ORGANIZATION
Organization
Healthier Choices Management Corp. (collectively, the “Company”, “we”,
“us” and “our”)) is a holding company focused on providing consumers with healthier daily choices with respect to nutrition and other lifestyle alternatives. The Company
currently operates nine retail vape stores in the Southeast region of the United States, through which it offers e-liquids, vaporizers and related products. The Company also operates Ada’s Natural Market, a natural and organic grocery store,
through its wholly owned subsidiary Healthy Choice Markets, Inc and Paradise Health and Nutrition, stores that offer fresh produce, bulk foods, vitamins and supplements, packaged groceries, meat and seafood, deli, baked goods, dairy products,
frozen foods, health & beauty products and natural household items through its wholly owned subsidiary Healthy Choice Markets 2, LLC. The Company also sells vitamins and supplements on the Amazon.com marketplace through its wholly owned
subsidiary Healthy U Wholesale, Inc. The Company markets the Q-Cup™ technology under the vape segment; this patented technology is based on a small, quartz cup called the Q-Cup™, which a customer partially fills with either cannabis or CBD
concentrate (approximately 50 mg) purchased from a third party. The Q-Cup™ is then inserted into the Q-Cup™ Tank or Globe, that heats the cup from the outside without coming in direct contact with the solid concentrate. This Q-Cup™ technology
provides significantly more efficiency and an “on the go” solution for consumers who prefer to vape concentrates either medicinally or recreationally.
COVID-19 Management Update
In March 2020, the outbreak of COVID-19 (coronavirus) caused by a novel strain of the coronavirus has recently been recognized as a pandemic by the World
Health Organization, and the outbreak has become increasingly widespread in the United States, including in the markets in which the Company operates. The COVID-19 outbreak has had a notable impact on general economic conditions, including but not
limited to the temporary closures of many businesses, “shelter in place” and other governmental regulations, reduced consumer spending due to both job losses and other effects attributable to the COVID-19, and there are many unknowns. The Company has
adjusted certain aspects of the operations to protect their employees and customers while still meeting customers’ needs. While to date the Company has not been required to close any of its stores, the Company is currently operating under regular
hours and we are expecting COVID-19 to have a long-term beneficial impact to the future financial results of the grocery segment. The Company continues to monitor the impact of the COVID-19 outbreak closely. The extent to which the COVID-19 outbreak
will impact our operations is controllable, and there is no imminent risk on business continuity and future operation.
Note 2. GOING CONCERN AND LIQUIDITY
The accompanying condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United
States of America (“GAAP”), which contemplate continuation of the Company as a going concern and realization of assets and satisfaction of liabilities in the normal course of business and do not include any adjustments that might result from the
outcome of any uncertainties related to our going concern assessment. The carrying amounts of assets and liabilities presented in the financial statements do not necessarily purport to represent realizable or settlement values.
The Company incurred a loss from operations of approximately $1.5 million for
the six months ended June 30, 2020. As of June 30, 2020, cash and cash equivalents totaled approximately $1.1 million, excluding a restricted cash of $2 million. While we anticipate that our current cash and cash equivalents to be generated from operations will be sufficient to meet our projected operating plans for the foreseeable future through a year and a day from the issuance
of these consolidated financial statements, should we require additional funds (either through equity or debt financings, collaborative agreements or from other sources), we have no commitments to obtain such additional financing and we may not be
able to obtain any such additional financing on terms favorable to us, or at all.
6
Note 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Reclassification
Certain amounts in the consolidated financial statements and related notes have been reclassified to conform to the current year presentation. Such
reclassifications do not impact the Company's previously reported financial position or net income (loss).
Use of Estimates in the Preparation of the Financial Statements
The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of net revenue and expenses during the reporting periods.
Actual results could differ from those estimates. These estimates and assumptions include allowances, reserves and write-downs of receivables and inventory, valuing equity securities and hybrid instruments, share-based payment arrangements, deferred
taxes and related valuation allowances, and the valuation of the assets and liabilities acquired in business combinations. Certain of management’s estimates could be affected by external conditions, including those unique to our industry, and general
economic conditions. It is possible that these external factors could have an effect on our estimates that could cause actual results to differ from our estimates. The Company re-evaluates all of its accounting estimates at least quarterly based on
these conditions and records adjustments when necessary.
Basis of Presentation and Principles of Consolidation
The Company’s unaudited condensed consolidated financial statements are prepared in accordance with GAAP. The unaudited condensed consolidated financial
statements include the accounts of all subsidiaries in which the Company holds a controlling financial interest as of the financial statement date.
The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Healthy Choice Markets, Inc., Healthy Choice
Markets 2, LLC (“Paradise Health and Nutrition”), The Vitamin Store, LLC, Healthy U Wholesale, Inc., The Vape Store, Inc. (“Vape Store”), Vaporin, Inc. (“Vaporin”), Smoke Anywhere U.S.A., Inc. (“Smoke”), Emagine the Vape Store, LLC (“Emagine”), IVGI
Acquisition, Inc., Vapormax Franchising LLC, Vaporin LLC, and Vaporin Florida, Inc. All intercompany accounts and transactions have been eliminated in consolidation.
Recently Adopted Accounting Pronouncements
The Company adopted Accounting Standards Update No. 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash (“ASU 2016-18”). The amendment requires
that the statement of cash flows explain the change during the period in the total cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. The Company adopted ASU 2016-18 in the second quarter of
2020 using the retrospective transition method to each period presented. The adoption primarily resulted in the inclusion of the restricted cash balances within the overall cash balances and a reconciliation of cash, cash equivalents and restricted
cash reported on the condensed consolidated balance sheet. The adoption of this standard did not have a material impact on the condensed consolidated financial statements and is not expected to have a material impact for the foreseeable future. See
“Cash and Cash Equivalents and Restricted Cash” above for further discussion of the effects of the adoption of ASU 2016-18 on the Company’s significant accounting policies.
Unaudited Interim Financial Information
The unaudited condensed consolidated financial statements have been prepared by the Company and reflect all normal, recurring adjustments that, in the
opinion of management, are necessary for a fair presentation of the interim financial information. The results of operations for the interim periods presented are not necessarily indicative of the results to be expected for any subsequent quarter or
for the year ending December 31, 2020. Certain information and footnotes normally included in financial statements prepared in accordance with GAAP have been omitted under the instructions to Form 10-Q and Article 10 of Regulation S-X of the
Securities and Exchange Commission (“SEC”). These unaudited condensed consolidated financial statements and notes included herein should be read in conjunction with the audited consolidated financial statements and related notes thereto as of and for
the year ended December 31, 2019 included in the Company’s Annual Report on Form 10-K for such year as filed with the SEC on May 13, 2020.
7
Note 4. CONCENTRATIONS
Cash and Cash Equivalents and
Restricted Cash
The following table provides a reconciliation of cash, cash equivalents and
restricted cash to amounts shown in the statement of cash flows:
|
|
June 30, 2020
|
|
|
December 31, 2019
|
||
Cash and Cash Equivalent
|
$
|
1,147,103
|
$
|
1,525,415
|
|||
Restricted cash, non-current portion
|
|
|
2,000,000
|
|
|
|
2,000,000
|
Total cash, cash equivalents and restricted cash
|
|
$
|
3,147,103
|
|
|
$
|
3,525,415
|
Restricted Cash
The Company’s restricted cash consists of cash that the Company is contractually obligated to maintain in a money market account in accordance with the terms
of its April 2018 revolving credit line agreement. See Note 8 for further discussion.
Note 5. DISAGGREGATION OF REVENUES
The Company reports the following segments in accordance with management guidance: Vapor and Grocery. When the Company prepares its internal management
reporting to evaluate business performance, we disaggregate revenue into the following categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.
Three Months Ended June 30,
|
Six Months Ended June 30,
|
||||||||||
2020
|
2019
|
2020
|
2019
|
||||||||
Vapor
|
$
|
520,877
|
$
|
1,085,259
|
$
|
1,294,334
|
$
|
2,309,300
|
|||
Grocery
|
2,788,035
|
2,731,754
|
6,050,749
|
5,887,819
|
|||||||
Total revenue
|
$
|
3,308,912
|
$
|
3,817,013
|
$
|
7,345,083
|
$
|
8,197,119
|
|||
Retail Vapor
|
$
|
520,877
|
$
|
1,085,181
|
$
|
1,294,334
|
$
|
2,308,904
|
|||
Retail Grocery
|
2,453,446
|
2,380,537
|
5,283,811
|
5,010,081
|
|||||||
Food service/restaurant
|
245,828
|
310,124
|
574,967
|
657,775
|
|||||||
Online/eCommerce
|
82,940
|
34,632
|
186,150
|
204,855
|
|||||||
Wholesale Grocery
|
5,821
|
6,462
|
5,821
|
15,107
|
|||||||
Wholesale Vapor
|
-
|
77
|
-
|
397
|
|||||||
Total revenue
|
$
|
3,308,912
|
$
|
3,817,013
|
$
|
7,345,083
|
$
|
8,197,119
|
Note 6. INTANGIBLE ASSETS
Intangible assets, net are as follows:
June 30, 2020
|
Useful Lives (Years)
|
Gross
Carrying Amount
|
Accumulated
Amortization
|
Net
Carrying Amount
|
||||||||
Trade names
|
8-10 years
|
$
|
993,000
|
$
|
(405,141)
|
$
|
587,859
|
|||||
Customer relationships
|
4-10 years
|
1,228,000
|
(419,385)
|
808,615
|
||||||||
Patents
|
10 years
|
359,665
|
(67,658)
|
292,007
|
||||||||
Non-compete
|
4 years
|
174,000
|
(67,063)
|
106,937
|
||||||||
Intangible assets, net
|
$
|
2,754,665
|
$
|
(959,247)
|
$
|
1,795,418
|
December 31, 2019
|
Useful Lives (Years)
|
Gross
Carrying Amount
|
Accumulated
Amortization
|
Net
Carrying Amount
|
||||||||
Trade names
|
8-10 years
|
$
|
993,000
|
(354,203)
|
$
|
638,797
|
||||||
Customer relationships
|
4-10 years
|
1,228,000
|
(293,260)
|
934,740
|
||||||||
Patents
|
10 years
|
270,250
|
(49,027)
|
221,223
|
||||||||
Non-compete
|
4 years
|
174,000
|
(45,313)
|
128,687
|
||||||||
Intangible assets, net
|
$
|
2,665,250
|
$
|
(741,803)
|
$
|
1,923,447
|
8
Intangible assets are amortized on a straight-line basis over their estimated useful lives. Amortization expense amounted to approximately $0.2 million and
$0.2 million for the six months ended June 30, 2020 and 2019, respectively. Future annual estimated amortization expense is as follows:
Years ending December 31,
|
||
2020 (remaining six months)
|
$
|
216,796
|
2021
|
426,591
|
|
2022
|
411,206
|
|
2023
|
172,341
|
|
2024
|
172,341
|
|
Thereafter
|
396,143
|
|
Total
|
$
|
1,795,418
|
Note 7. CONTRACT LIABILITIES
The Company’s contract liabilities consists of gift cards and loyalty rewards, for which the Company has a performance obligation to deliver products when
customers redeem balances or terms expire through breakage. Our breakage policy is twenty four-month for gift cards, twelve months for Grocery loyalty rewards, and six months for Vapor loyalty rewards. As such, all contract liabilities are expected
to be recognized within a twenty four-month period. Revenue is recognized when gift card and loyalty points are redeemed.
A summary of the net changes in contract liabilities activity for the six months ended June 30, 2020 and 2019 is presented below:
As of June 30,
|
|||||
2020
|
2019
|
||||
Beginning balance as January 1,
|
$
|
26,823
|
$
|
442,630
|
|
Issued
|
42,611
|
64,452
|
|||
Redeemed
|
(47,580)
|
(67,781)
|
|||
Breakage recognized
|
(244)
|
(1,222)
|
|||
Fulfillment of contract
|
(224)
|
(270,698)
|
|||
Ending balance as of June 30,
|
$
|
21,386
|
$
|
167,381
|
Note 8. DEBT
Line of Credit
On April 13, 2018, the Company agreed to a new revolving credit line of $2 million and a money market account of $2 million (“blocked account”) with
Professional Bank in Coral Gables, Florida. On June 30, 2020, the Company reached agreement with Professional Bank to renew the credit line for one more year, and the next annual review will occur on or before July 15, 2021. The new agreement
included a variable interest rate that it is based on a rate of 1.5% over what is earned on the collateral amount. The collateral amount established in the arrangement with the bank is $2 million. As of June 30, 2020, the Company had $2 million in
the blocked account, which is recorded as restricted cash included in non-current assets.
Paycheck Protection Program
On May 15, 2020, the Company was granted a loan (the “Loan”) from Customers Bank, in the aggregate amount of
$876,515, pursuant to the Paycheck Protection Program (the “PPP”) under Division A, Title I of the CARES Act, which was enacted March 27, 2020.
The Loan, which was in the form of a Note dated May 6, 2020 issued by the Company, matures on May 6, 2022 and
bears interest at a rate of 1% per annum, payable monthly commencing on November 6, 2020. The Note may be prepaid by the Borrower at any time prior to maturity with no prepayment penalties. Funds from the Loan may only be used for payroll costs,
costs used to continue group health care benefits, mortgage payments, rent, utilities, and interest on other debt obligations incurred after May 6, 2020. The Company intends to use the entire Loan amount for these qualifying expenses. Under the
terms of the PPP, certain amounts of the Loan may be forgiven if they are used for qualifying expenses as described in the CARES Act.
Note 9. STOCKHOLDERS’ EQUITY
Series A Warrants
In the six months ended June 30, 2020, the Company issued 19.9 billion shares in connection with the cashless exercise of the Series A warrants.
9
Stock Options
A summary of Stock-based compensation expense recognized is presented below:
Three Months Ended June 30,
|
Six Months Ended June 30,
|
||||||||||
2020
|
2019
|
2020
|
2019
|
||||||||
Stock-based compensation
|
$
|
(7,665)
|
$
|
83,175
|
$
|
74,279
|
$
|
196,254
|
Income (Loss) Per Share
The following table summarizes the Company’s securities, in common share equivalents, that have been excluded from the calculation of dilutive loss per
share as their effect would be anti-dilutive:
As of June 30,
|
||||||||
2020
|
2019
|
|||||||
Preferred stock
|
201,501,000,000
|
201,501,000,000
|
||||||
Stock options
|
68,062,000,000
|
68,012,000,000
|
||||||
Warrants
|
36,460,000,000
|
41,579,000,000
|
||||||
Total
|
306,023,000,000
|
311,092,000,000
|
Note 10. COMMITMENTS AND CONTINGENCIES
Legal Proceedings
Two lawsuits were filed against the Company and its subsidiaries in connection with alleged claimed battery defects for an electronic cigarette device.
Plaintiffs claim these batteries were sold by a store of the Company’s subsidiary and have sued for an undetermined amount of damages (other than a total of $0.4 million of medical costs). The initial complaints were filed between January 2019 and
April 2019. We responded to the complaints on April 2019 and May 2019, respectively. Given the lack of information presented by the plaintiffs to date, the Company is unable to predict the outcome of these matters and, at this time, cannot reasonably
estimate the possible loss or range of loss with respect to these legal proceedings.
As of June 30, 2020, the Company has not accrued for a potential loss for these actions. Given the information received to date, the Company believes the
allegations are without merit and intends to vigorously contest such actions. These lawsuits remain in the early stages and progressed minimally in 2020. With respect to
legal costs, we record such costs as incurred.
Note 11. SUBSEQUENT EVENTS
The Company evaluated subsequent events through August 19, 2020, the date on which the June 30, 2020 unaudited condensed financial statements were
originally issued. There are no significant events that require disclosure in these financial statements, except as follows:
Cashless Exercises of Series A Warrants
From July 1, 2020 through August 19, 2020, the Company issued 17.6 billion of common stock shares in connection with Series A Warrants exercises.
Expiration of Series A Warrants
On July 27, 2020, the remaining Company Series A Warrants expired and the balance of outstanding warrants not exercised was 355,661 warrants.
Renewal of Credit Line
On April 13, 2018, the Company agreed to a new revolving credit line of $2 million and a money market account of $2 million (“blocked account”) with
Professional Bank in Coral Gables, Florida. On August 4, 2020, the Company reached agreement with Professional Bank to renew the credit line thru May 13, 2022, and the next review will occur on or before the expiration date. The new agreement
included a variable interest rate that it is based on a rate of 1.50% over what is earned on the collateral amount. The collateral amount established in the arrangement with the bank is $2 million.
Term Loan and Security Agreement
On August 18, 2020, the Company agreed to a term loan and security agreement (the “Loan”) in the aggregate of $2.7 million with Sabby Healthcare Master
Fund, LTD and Sabby Volatility Warrant Master Fund, LTD (“collectively, the Lender”). The loan has a non-refundable discount of 5% to the face amount of the loan and it matures on November 16, 2020. The proceeds received from the Loan will be used
solely for the purchase of personal protective equipment (“PPE”) and any related expenses from the transactions. The Lender is entitled to 20% of all Net profits received from the sales of the PPE goods through the maturity date.
10
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF CONDENSED
CONSOLDIATED OPERATIONS
The following discussion and analysis should be read in conjunction with our unaudited interim condensed consolidated financial statements and related
notes appearing elsewhere in this report on Form 10-Q. In addition to historical information, this discussion and analysis contains forward-looking statements that involve risks, uncertainties, and assumptions. Our actual results may differ
materially from those anticipated in these forward-looking statements. The terms “we,” “us,” “our,” and the “Company” refer to Healthier Choices Management Corp. and its wholly-owned subsidiaries, Healthy Choice Markets, Inc., Healthy Choice Markets
2, LLC (“Paradise Health and Nutrition”), The Vitamin Store, LLC, Healthy U Wholesale, Inc., The Vape Store, Inc. (“Vape Store”), Vaporin, Inc. (“Vaporin”), Smoke Anywhere U.S.A., Inc. (“Smoke”), Emagine the Vape Store, LLC (“Emagine”), IVGI
Acquisition, Inc., Vapormax Franchising LLC, Vaporin LLC, and Vaporin Florida, Inc. . All intercompany accounts and transactions have been eliminated in consolidation.
Company Overview
Healthier Choices Management Corp. (collectively, the “Company”, “we”,
“us” and “our”) is a holding company focused on providing consumers with healthier daily choices with respect to nutrition and other lifestyle alternatives. The Company
currently operates nine retail vape stores in the Southeast region of the United States, through which it offers e-liquids, vaporizers and related products. The Company markets its Q-Cup™ technology under the vape segment. This Q-Cup™ technology
provides significantly more efficiency and an “on the go” solution for consumers who prefer to vape concentrates either medicinally or recreationally. In October 2019, the Company announced the launch of the Q-Unit, a U.S. patented device
made specifically for vaping concentrates. The Q-Unit, which boasts a mechanism that prevents the concentrates from coming in direct contact with the heating element, allows consumers to vape uncut pure extract from a pure quartz cup. The Company also operates Ada’s Natural Market, a natural and organic grocery store, through its wholly owned subsidiary Healthy Choice Markets, Inc. and Paradise Health and
Nutrition, stores that offer fresh produce, bulk foods, vitamins and supplements, packaged groceries, meat and seafood, deli, baked goods, dairy products, frozen foods, health & beauty products and natural household items through its wholly
owned subsidiary Healthy Choice Markets 2, LLC.
Going Concern and Liquidity
The unaudited condensed consolidated financial statements included elsewhere in this Form 10-Q have been prepared in conformity with GAAP, which
contemplate continuation of the Company as a going concern and realization of assets and satisfaction of liabilities in the normal course of business and do not include any adjustments that might result from the outcome of any uncertainties related
to our going concern assessment. The carrying amounts of assets and liabilities presented in the financial statements do not necessarily purport to represent realizable or settlement values. The unaudited consolidated financial statements do not
include any adjustments that might result from the outcome of these uncertainties.
The Company incurred a loss from operations of approximately $1.5 million for the six months ended June 30, 2020. As of June 30, 2020, cash and cash
equivalents totaled approximately $1.1 million. While we anticipate that our current cash, cash equivalents, and cash to be generated from operations will be sufficient to meet our projected operating plans for the foreseeable future through a year
and a day from the issuance of these unaudited consolidated financial statements, should we require additional funds (either through equity or debt financings, collaborative agreements or from other sources) we have no commitments to obtain such
additional financing, and we may not be able to obtain any such additional financing on terms favorable to us, or at all. If adequate financing is not available, the Company will further delay, postpone or terminate product and service expansion and
curtail certain selling, general and administrative operations. The inability to raise additional financing may have a material adverse effect on the future performance of the Company.
Factors Affecting Our Performance
We believe the following factors affect our performance:
Vapor Retail: We believe the
operating performance of our vapor retail stores will affect our revenue and financial performance. The Company has a total of nine retail vape stores, which are located in Florida, Georgia and Tennessee.
Inventory Management: Our vapor
segment revenue trends are affected by an evolving product acceptance and consumer demand. We are creating and offering new products to our retail vapor customers. Evolving product development and technology impacts our licensing and intellectual
properties spending. We expect the transition to vaporizer and advanced technology and enhanced performance products to continue and will impact our overall operating results in the future.
Increased Competition: The launch
by national competitors in both of our business reporting segments have made it more difficult to compete on prices and to secure business. We expect increased product supply and downward pressure on prices to continue and impact our operating
results in the future. We also expect the continued expansion of national grocery chains, which leads to greater competition, to impact our operating results in the future.
11
Results of Operations
The following table sets forth our unaudited condensed consolidated Statements of Operations for the three months ended June 30, 2020 and 2019 that is used
in the following discussions of our results of operations:
Three Months Ended June 30,
|
2020 to 2019
|
|||||||
2020
|
2019
|
Change $
|
||||||
SALES
|
||||||||
Vapor sales, net
|
$
|
520,877
|
$
|
1,085,259
|
$
|
(564,382)
|
||
Grocery sales, net
|
2,788,035
|
2,731,754
|
56,281
|
|||||
TOTAL SALES, NET
|
3,308,912
|
3,817,013
|
(508,101)
|
|||||
Cost of sales vapor
|
212,457
|
442,931
|
(230,474)
|
|||||
Cost of sales grocery
|
1,723,161
|
1,711,791
|
11,370
|
|||||
GROSS PROFIT
|
1,373,294
|
1,662,291
|
(288,997)
|
|||||
OPERATING EXPENSES
|
||||||||
Selling, general and administrative
|
2,168,159
|
2,534,492
|
(366,333)
|
|||||
Total operating expenses
|
2,168,159
|
2,534,492
|
(366,333)
|
|||||
LOSS FROM OPERATIONS
|
(794,865)
|
(872,201)
|
77,336
|
|||||
OTHER INCOME (EXPENSE)
|
||||||||
Gain (loss) on investment
|
(1,286)
|
(19,286)
|
18,000
|
|||||
Interest income (expense)
|
(22,529)
|
(12,827)
|
(9,702)
|
|||||
Total other income (expense), net
|
(23,815)
|
(32,113)
|
8,298
|
|||||
NET LOSS
|
$
|
(818,680)
|
$
|
(904,314)
|
$
|
85,634
|
Net Vapor sales decreased $0.6 million to $0.5 million for the three months ended June 30, 2020 as compared to $1.1 million for the same period in 2019.
The decrease in sales is primarily due to a major decreased in foot traffic or temporary closure of some stores a result of the Coronavirus (COVID-19) pandemic during the three months ended June 30, 2020 as compared to the same period in 2019.
Net Grocery sales increased $0.1 million to $2.8 million for the three months
ended June 30, 2020 as compared to $2.7 million for the same period in 2019. The increase in sales is primarily due to COVID-19 pandemic and the company new strategy to offer its customer the option to delivery or curb side pickup their
orders.
Vapor cost of goods sold for the three months ended June 30, 2020 and 2019 were $0.2 million and $0.4 million, respectively, a decreased of $0.2 million.
The decrease is primarily due to decreases in product costs during three months ended June 30, 2020 as compared to the same period in 2019. Gross profit was $0.3 million and $0.6 million for three months ended June 30, 2020 and 2019, respectively.
Grocery cost of goods sold for the three months ended June 30, 2020 and 2019 were $1.7 million and $1.7 million respectively, an increased of $11,000. The
increase is primarily due to increases in sales and cost of goods sold from the COVID-19 pandemic. Gross profit was $1.1 million and $1.0 million for the three months ended June 30, 2020 and 2019, respectively.
Selling, general and administrative expenses decreased $0.4 million to $2.2 million for the three months ended June 30, 2020 compared to $2.5 million for
the same period in 2019. The decrease is primarily attributable to decreases in payroll and employee related cost of $0.1 million, stock compensation of $0.1 million, meals, meals, travel and entertainment of $41,000, occupancy of $28,000, and
insurance of $27,000.
Net other expense of $24,000 for the three months ended June 30, 2020 includes
interest expense of $23,000, and loss on investment of $1,000, and Net other expense of $32,000 for the three months ended June 30, 2019 includes a loss on investment of $19,000, partially offset by interest income of $13,000.
12
The following table sets forth our unaudited consolidated Statements of Operations for the six months ended June 30, 2020 and 2019 that is used in the
following discussions of our results of operations:
Six Months Ended
June 30,
|
2020 to 2019
|
|||||||
2020
|
2019
|
Change $
|
||||||
SALES
|
||||||||
Vapor sales, net
|
$
|
1,294,334
|
$
|
2,309,300
|
$
|
(1,014,966)
|
||
Grocery sales, net
|
6,050,749
|
5,887,819
|
162,930
|
|||||
TOTAL SALES, NET
|
7,345,083
|
8,197,119
|
(852,036)
|
|||||
Cost of sales vapor
|
531,537
|
952,347
|
(420,810)
|
|||||
Cost of sales grocery
|
3,732,362
|
3,679,587
|
52,775
|
|||||
GROSS PROFIT
|
3,081,184
|
3,565,185
|
(484,001)
|
|||||
OPERATING EXPENSES
|
||||||||
Selling, general and administrative
|
4,540,540
|
5,524,947
|
(984,407)
|
|||||
Total operating expenses
|
4,540,540
|
5,524,947
|
(984,407)
|
|||||
LOSS FROM OPERATIONS
|
(1,459,356)
|
(1,959,762)
|
500,406
|
|||||
OTHER INCOME (EXPENSE)
|
||||||||
Gain (loss) on investment
|
(11,143)
|
(44,999)
|
33,856
|
|||||
Interest income (expense)
|
(39,475)
|
(12,082)
|
(27,393)
|
|||||
Total other income (expense), net
|
(50,618)
|
(57,081)
|
6,463
|
|||||
NET LOSS
|
$
|
(1,509,974)
|
$
|
(2,016,843)
|
$
|
506,869
|
Net Vapor sales decreased $1.0 million to $1.3 million for the six months ended June 30, 2020 as compared to $2.3 million for the same period in 2019. The
decrease in sales is primarily due to a major decreased in foot traffic or temporary closure of some stores a result of the Coronavirus (COVID-19) pandemic and a decrease in the number of stores open during the six months ended June 30, 2020 as
compared to the same period in 2019.
Net Grocery sales increased $0.2 million to $6.1 million for the six months
ended June 30, 2020 as compared to $5.9 million for the same period in 2019. The increase in sales is primarily due to COVID-19 pandemic and the company new strategy to offer its customer the option to delivery or curb side pickup their
orders.
Vapor cost of goods sold for the six months ended June 30, 2020 and 2019 were $0.5 million and $1.0 million, respectively, a decrease of $0.4 million. The
decrease is primarily due to a decreased in sales and product cost. Gross profit was $0.8 million and $1.4 million for the six months ended June 30, 2020 and 2019, respectively.
Grocery cost of goods sold for the six months ended June 30, 2020 and 2019 were $3.7 million and $3.7 million, respectively, an increase of $0.1 million.
The increase is primarily due to increases in sales and cost of goods sold from the COVID-19 pandemic. Gross profit was $2.3 million and $2.2 million for the six months ended June 30, 2019 and 2019, respectively.
Selling, general and administrative expenses decreased $1.0 million to $4.5 million for the six months ended June 30, 2020 compared to $5.5 million for the
same period in 2019. The decrease is primarily attributable to increases in payroll and employee related cost of $0.5 million, stock-based compensation of $0.1 million, professional fees of $0.1 million, taxes, licenses & permits of $0.1 million,
insurance of $45,000, and occupancy of $32,000.
Net other expense of $0.1 million for the six months ended June 30, 2020 was
primarily due to an interest expense of $39,000, and a loss on investment of $11,000. Net other expense of $0.1 million for the six months ended June 30, 2019 includes a loss on investment of 45,000, and interest expense of $12,000.
The company did not incur activity from discontinued operations for the six months ended June 30, 2020 or for the same period in 2019.
13
Liquidity and Capital Resources
Six Months Ended June 30,
|
|||||
2020
|
2019
|
||||
Net cash used in operating activities
|
$
|
(1,010,905)
|
$
|
(2,089,988)
|
|
Net cash provided by (used in) investing activities
|
(104,087)
|
57,570
|
|||
Net cash provided by financing activities
|
736,680
|
13,777
|
|||
$
|
(378,312)
|
$
|
(2,018,641)
|
Our net cash used in operating activities of $1.0 million for the six months
ended June 30, 2020 resulted from a net loss of $1.5 million, and a net cash usage of $0.1 million from changes in operating assets and liabilities, offset by a non-cash adjustment of $0.6 million. Our net cash used in operating activities of $2.1 million for the six months ended June 30, 2019 resulted from a net loss of $2.0 million and a net cash usage of $1.0 million from changes in operating
assets and liabilities, offset by a non-cash adjustment of $0.9 million.
The net cash used in investing activities of $0.1 million for the six months
ended June 30, 2020 resulted from the issuance and collection of a note receivable, and purchases of a patent and property and equipment. The net cash provided by
investing activities of $58,000 for the six months ended June 30, 2019 resulted from payments received on the VPR Brands L.P. Note.
The net cash provided by financing activities of $0.7 million for the six
months ended June 30, 2020 is due to proceeds received from the Payroll Protection Plan of $0.9 million, offset by loan of payments of $0.7 million on the loan payable. The net cash provided by financing activities of $14,000 for the six months
ended June 30, 2019 is due to payments on the loan payable.
At June 30, 2020 and December 31, 2019, we did not have any material financial guarantees or other contractual commitments with vendors that are reasonably
likely to have an adverse effect on liquidity.
Our cash balances are kept liquid to support our growing acquisition and infrastructure needs for operational expansion. The majority of our cash and cash
equivalents are concentrated in three financial institutions and are generally in excess of the FDIC insurance limit. The Company has not experienced any losses on its cash and cash equivalents. The following table presents the Company’s cash
position as of June 30, 2020 and December 31, 2019.
June 30,
2020
|
December 31,
2019
|
||||
Cash
|
$
|
1,147,103
|
$
|
1,525,415
|
|
Total assets
|
$
|
13,177,057
|
$
|
13,177,057
|
|
Percentage of total assets
|
8.71%
|
11.58%
|
The Company reported a net loss of $1.5 million for the six months ended June 30, 2020. The Company also had negative working capital of $0.9 million. The
Company expects to continue incurring losses for the foreseeable future and may need to raise additional capital to satisfy warrant obligations, and to continue as a going concern.
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements.
Critical Accounting Policies and Estimates
Our management’s discussion and analysis of financial condition and results of operations is based on our unaudited condensed consolidated financial
statements, which have been prepared in accordance with accounting principles generally accepted in the United States, or U.S. GAAP. The preparation of these condensed consolidated financial statements requires us to exercise considerable judgment
with respect to establishing sound accounting policies and in making estimates and assumptions that affect the reported amounts of our assets and liabilities, our recognition of revenues and expenses, and disclosure of commitments and contingencies
at the date of the condensed consolidated financial statements.
We base our estimates on our historical experience, knowledge of our business and industry, current and expected economic conditions, the attributes of our
products, the regulatory environment, and in certain cases, the results of outside appraisals. We periodically re-evaluate our estimates and assumptions with respect to these judgments and modify our approach when circumstances indicate that
modifications are necessary. These estimates and assumptions form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.
14
While we believe that the factors we evaluate provide us with a meaningful basis for establishing and applying sound accounting policies, we cannot
guarantee that the results will always be accurate. Since the determination of these estimates requires the exercise of judgment, actual results could differ from such estimates.
There have been no material changes to the Company’s critical accounting policies and estimates as compared to the critical accounting policies and
estimates described in the 2019 Annual Report, which we believe are the most critical to our business and the understanding of our results of operations and affect the more significant judgments and estimates that we use in the preparation of our
condensed consolidated financial statements.
Seasonality
We do not consider our business to be seasonal.
Cautionary Note Regarding Forward-Looking Statements
This report includes forward-looking statements including statements regarding retail expansion, the future demand for our products, the transition to
vaporizer and other products, competition, the adequacy of our cash resources and our authorized Common Stock, and our continued ability to raise capital.
The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect”
and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we
believe may affect our financial condition, results of operations, business strategy and financial needs.
The results anticipated by any or all of these forward-looking statements might not occur. Important factors that could cause actual results to differ from
those in the forward-looking statements include our future common stock price, the timing of future warrant exercises and stock sales, having the authorized capital to issue stock to exercising Series A Warrant holders, customer acceptance of our
products, and proposed federal and state regulation. We undertake no obligation to publicly update or revise any forward-looking statements, whether as the result of new information, future events or otherwise.
15
Not applicable to smaller reporting companies.
Evaluation of Disclosure Controls and Procedures
Our management, including our Principal Executive Officer and Principal Financial Officer, did not carry out an evaluation on internal controls as of June
30, 2020 in regard to the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, or the Exchange Act. As an evaluation was not carried out, our Principal Executive
Officer and Principal Financial Officer concluded that our disclosure controls and procedures were ineffective as of the end of the period covered by this report.
In planning and performing its audit of our financial statements for the year ended December 31, 2019 in accordance with standards of the Public Company
Accounting Oversight Board, our independent registered public accounting firm noted material weaknesses in internal control over financial reporting. A list of our material weaknesses are as follows:
● |
Failure to have properly documented and designed disclosure controls and procedures and testing of the operating effectiveness of our internal control over financial
reporting
|
● |
Weakness around our purchase orders and inventory write-off procedures
|
● |
Segregation of duties due to lack of personnel
|
During the second quarter of 2020, the Company's independent auditors
identified a material weakness in our internal controls and procedures over the adoption of Accounting Standard Codification ("ASC") 230, Restricted cash. The material weakness in internal control over financial reporting resulted in a
reclassification to the presentation of the Company's prior period financial statements. These reclassifications were done to conform to the presentation of the current financial statement and they had no effect on the previously reported net loss.
Our management concluded that considering internal control deficiencies that, in the aggregate, rise to the level of material weaknesses, we did not
maintain effective internal control over financial reporting as of June 30, 2020 based on the criteria set forth in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”).
Changes in Internal Control over Financial Reporting
Following this assessment and during the six months ended June 30, 2020, we have undertaken an action plan to
strengthen internal controls and procedures:
● |
We continue to improve the process around inventory controls and
throughout the current year, we are planning to perform a blind-counts for 100% of our overall inventory value with the purpose of validating our inventory records and increasing the staff knowledge around the importance of the new
inventory procedures implemented. In addition, we are transitioning the independent third-party counts to a new company with the purposes of improving the accuracy of the quarterly and yearly counts perform for all retail stores. Due to the
Coronavirus pandemic ("COVID-19") that started in early March 2020, the company was not able to conduct any independent third-party counts for the six months ended June 30, 2020.
|
● |
Our management has increased its focus on the Company’s purchase order process in order to better manage inventory thereby
improving cash management and ultimately leading to more reliable and precise financial reporting.
|
Our management continues to review ways in which we can make improvements in internal control over financial reporting.
16
Two lawsuits were filed against the Company and its subsidiaries in connection with alleged claimed battery defects for an electronic cigarette device.
Plaintiffs claim these batteries were sold by a store of the Company’s subsidiary and have sued for an undetermined amount of damages (other than a total of $0.4 million of medical costs). The initial complaints were filed between January 2019 and
April 2019. We responded to the complaints on April 2019 and May 2019, respectively. Given the lack of information presented by the plaintiffs to date, the Company is unable to predict the outcome of these matters and, at this time, cannot reasonably
estimate the possible loss or range of loss with respect to these legal proceedings.
As of June 30, 2020, the Company has not accrued for a potential loss for these actions. Given the information received to date, the Company believes the
allegations are without merit and intends to vigorously contest such actions. These lawsuits remain in the early stages and progressed minimally in 2020. With respect to
legal costs, we record such costs as incurred.
Not Applicable.
None.
None.
Not Applicable.
Not Applicable.
See the exhibits listed in the accompanying “Index to Exhibits.”
17
INDEX TO EXHIBITS
Exhibit
|
Incorporated by Reference
|
Filed or Furnished
|
||||||||
No.
|
Exhibit Description
|
Form
|
Date
|
Number
|
Herewith
|
|||||
31.1
|
Filed
|
|||||||||
31.2
|
Filed
|
|||||||||
32.1
|
Furnished *
|
|||||||||
32.2
|
Furnished *
|
|||||||||
101.INS
|
XBRL Instance Document
|
Filed
|
||||||||
101.SCH
|
XBRL Taxonomy Extension Schema Document
|
Filed
|
||||||||
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
Filed
|
||||||||
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document
|
Filed
|
||||||||
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document
|
Filed
|
||||||||
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
Filed
|
* |
This exhibit is being furnished rather than filed and shall not be deemed incorporated by reference into any filing, in accordance with Item 601 of Regulation S-K.
|
18
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
HEALTHIER CHOICES MANAGEMENT CORP.
|
||
Date: August 19, 2020
|
By:
|
/s/ Jeffrey Holman
|
Jeffrey Holman
|
||
Chief Executive Officer
|
||
Date: August 19, 2020
|
By:
|
/s/ John Ollet
|
John Ollet
|
||
Chief Financial Officer
|
19